تفاعل #55416

ord-0814228fd3c04f48a650f123d503d391

معادلة التفاعل

NC1C(=O)N2C(C(=O)O)=C(C(CC(=O)O)Sc3nnn[nH]3)CS[C@H]12
7-Amino-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
CN(C)C=O
dimethylformamide
CCN(CC)CC
triethylamine
CC(C)(C)OC(=O)C(C(N)=O)c1cccs1
α-t-butoxycarbonylthienylacetamide
CN(C)C=O
dimethylformamide
CC(C)(C)OC(=O)C(C(=O)NC1C(=O)N2C(C(=O)O)=C(C(CC(=O)O)Sc3nnn[nH]3)CS[C@H]12)c1cccs1
7-(α-t-butoxycarbonylthienylacetamido)-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid

المذيبات

ظروف التفاعل

الظروف التفصيلية
See reaction.notes.procedure_details.

المعالجة

  1. 1
    workup.STIRRINGthe mixture stirred another five hours
  2. 2
    أخرىthe solution was decanted
  3. 3
    غسيلThe remaining oily material was washed with ether
  4. 4
    workup.DISSOLUTIONdissolved in water
  5. 5
    استخلاصthe aqueous solution was extracted with ethyl acetate
  6. 6
    workup.ADDITIONThe pH of the ethyl acetate solution was adjusted to 1.5 by addition of dilute hydrochloric acid
  7. 7
    استخلاصExtraction
  8. 8
    أخرىwith ethyl acetate and evaporation of the solvent

الإجراء التجريبي

7-Amino-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid (1.0 g., 2.68 mmol.) was suspended in 10 ml. of dry dimethylformamide and 1.12 ml of triethylamine was added followed by 85 drops of formamide. A solution of 0.91 g. (2.68 mmol.) of the activated ester of α-t-butoxycarbonylthienylacetamide, prepared as described above, in 2 ml. of dimethylformamide was added and the reaction mixture was stirred at 25° for three hours. An additional 0.45 g. of activated ester was then added and the mixture stirred another five hours. Ether (ca. 300 ml.) was added and the solution was decanted. The remaining oily material was washed with ether, dissolved in water and the aqueous solution was extracted with ethyl acetate. The pH of the ethyl acetate solution was adjusted to 1.5 by addition of dilute hydrochloric acid. Extraction with ethyl acetate and evaporation of the solvent gave 7-(α-t-butoxycarbonylthienylacetamido)-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid.

المصدر

DOI: 10.6084/m9.figshare.5104873.v1براءة الاختراع: US04220644uspto-grants-1980_09